These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21183370)

  • 81. Factors with impact on magnitude of the placebo response in randomized, controlled, cross-over trials in peripheral neuropathic pain.
    Gillving M; Demant D; Lund K; Holbech JV; Otto M; Vase L; Jensen TS; Bach FW; Finnerup NB; Sindrup SH
    Pain; 2020 Dec; 161(12):2731-2736. PubMed ID: 32569087
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Treatment adherence with levetiracetam: a non-interventionist retrospective observation-based study].
    Serrano-Castro PJ; Mauri-Llerda JA; Garcia A; Rocamora R; Pardo-Merino A; Garcia-Garcia P
    Rev Neurol; 2016 Jun; 62(11):481-6. PubMed ID: 27222081
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Painful polyneuropathy.
    Galer BS
    Neurol Clin; 1998 Nov; 16(4):791-812. PubMed ID: 9767063
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Levetiracetam improves symptoms of multiple chemical sensitivity: Case report.
    Kakisaka Y; Jin K; Fujikawa M; Kitazawa Y; Kato K; Nakasato N
    J Med Invest; 2017; 64(3.4):296-298. PubMed ID: 28955000
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Rare Case of Reversible Polyneuropathy after Levetiracetam Overdose.
    Moon P; Ramteke S; Mahajan L
    Neurol India; 2021; 69(6):1841-1843. PubMed ID: 34979704
    [No Abstract]   [Full Text] [Related]  

  • 86. The impact of pain in polyneuropathy.
    Gemignani F
    Eur J Pain; 2012 Jul; 16(6):944-5; author reply 946-7. PubMed ID: 22539445
    [No Abstract]   [Full Text] [Related]  

  • 87. Evaluation of levetiracetam as a pre-operative anxiolytic: A randomized, double-blind, placebo-controlled study.
    Choupoo NS; Das SK; Momin K; Das N; Das H
    Indian J Anaesth; 2015 Aug; 59(8):507-9. PubMed ID: 26379296
    [No Abstract]   [Full Text] [Related]  

  • 88. SANAD II: Dear Levetiracetam, the Honeymoon Is Over.
    Bermeo-Ovalle A
    Epilepsy Curr; 2022; 22(1):18-21. PubMed ID: 35233190
    [No Abstract]   [Full Text] [Related]  

  • 89. Levetiracetam in patients with central neuropathic post-stroke pain--a randomized, double-blind, placebo-controlled trial.
    Jungehulsing GJ; Israel H; Safar N; Taskin B; Nolte CH; Brunecker P; Wernecke KD; Villringer A
    Eur J Neurol; 2013 Feb; 20(2):331-7. PubMed ID: 22925226
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A randomized, placebo-controlled trial of levetiracetam in central pain in multiple sclerosis.
    Falah M; Madsen C; Holbech JV; Sindrup SH
    Eur J Pain; 2012 Jul; 16(6):860-9. PubMed ID: 22337561
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Antiseizure Medications for the Prophylaxis of Migraine during the Anti- CGRP Drugs Era.
    Rollo E; Romozzi M; Vollono C; Calabresi P; Geppetti P; Iannone LF
    Curr Neuropharmacol; 2023; 21(8):1767-1785. PubMed ID: 36582062
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Pharmacological Profile of MP-101, a Novel Non-racemic Mixture of R- and S-dimiracetam with Increased Potency in Rat Models of Cognition, Depression and Neuropathic Pain.
    Bonifacino T; Micheli L; Torazza C; Ghelardini C; Farina C; Bonanno G; Milanese M; Di Cesare Mannelli L; Scherz MW
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552791
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Pharmacological Management of Painful Peripheral Neuropathies: A Systematic Review.
    Liampas A; Rekatsina M; Vadalouca A; Paladini A; Varrassi G; Zis P
    Pain Ther; 2021 Jun; 10(1):55-68. PubMed ID: 33145709
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Drug therapy for chronic idiopathic axonal polyneuropathy.
    Warendorf J; Vrancken AF; van Schaik IN; Hughes RA; Notermans NC
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD003456. PubMed ID: 28631805
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Levetiracetam synergizes with gabapentin, pregabalin, duloxetine and selected antioxidants in a mouse diabetic painful neuropathy model.
    Stepanović-Petrović R; Micov A; Tomić M; Pecikoza U
    Psychopharmacology (Berl); 2017 Jun; 234(11):1781-1794. PubMed ID: 28332005
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Current Status of the New Antiepileptic Drugs in Chronic Pain.
    Sidhu HS; Sadhotra A
    Front Pharmacol; 2016; 7():276. PubMed ID: 27610084
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Levetiracetam for neuropathic pain in adults.
    Wiffen PJ; Derry S; Moore RA; Lunn MP
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD010943. PubMed ID: 25000215
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Update on neuropathic pain treatment: ion channel blockers and gabapentinoids.
    Chen L; Mao J
    Curr Pain Headache Rep; 2013 Sep; 17(9):359. PubMed ID: 23888370
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Neurovascular unit in chronic pain.
    Radu BM; Bramanti P; Osculati F; Flonta ML; Radu M; Bertini G; Fabene PF
    Mediators Inflamm; 2013; 2013():648268. PubMed ID: 23840097
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.